Literature DB >> 2356469

The need for central and peripheral tolerance in the B cell repertoire.

C C Goodnow1, S Adelstein, A Basten.   

Abstract

The immune system normally avoids producing antibodies that react with autologous ("self") antigens by censoring self-reactive T and B cells. Unlike the T cell repertoire, antibody diversity is generated within the B cell repertoire in two phases; the first occurs by gene rearrangement in primary lymphoid organs, and the second phase involves antigen-driven hypermutation in peripheral lymphoid organs. The possibility that distinct cellular mechanisms may impose self tolerance at these two different phases of B cell diversification may explain recent findings in transgenic mouse models, in which self-reactive B cells appear to be silenced both by functional inactivation and by physical elimination.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2356469     DOI: 10.1126/science.2356469

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  29 in total

Review 1.  Central nervous system mechanisms in Sjögren's syndrome.

Authors:  O P van Bijsterveld; A A Kruize; R L A W Bleys
Journal:  Br J Ophthalmol       Date:  2003-02       Impact factor: 4.638

Review 2.  T cells causing immunological disease.

Authors:  R M Zinkernagel; H Pircher; P S Ohashi; H Hengartner
Journal:  Springer Semin Immunopathol       Date:  1992

3.  IgE-secreting cells in the thymus: correlation with induction of tolerance to IgE.

Authors:  S Haba; A Nisonoff
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

Review 4.  B lymphocytes: how they develop and function.

Authors:  Tucker W LeBien; Thomas F Tedder
Journal:  Blood       Date:  2008-09-01       Impact factor: 22.113

5.  Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions.

Authors:  J M Eris; A Basten; R Brink; K Doherty; M R Kehry; P D Hodgkin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

6.  Peripheral deletion of rheumatoid factor B cells after abortive activation by IgG.

Authors:  H Tighe; K Warnatz; D Brinson; M Corr; W O Weigle; S M Baird; D A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

7.  Redemption of autoreactive B cells.

Authors:  Barton F Haynes; Laurent Verkoczy; Garnett Kelsoe
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-11       Impact factor: 11.205

Review 8.  Pharmacodynamics and toxicodynamics of drug action: signaling in cell survival and cell death.

Authors:  A N Kong; S Mandlekar; R Yu; W Lei; A Fasanmande
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

Review 9.  Neurotrophins and B-cell malignancies.

Authors:  Jennifer Hillis; Michael O'Dwyer; Adrienne M Gorman
Journal:  Cell Mol Life Sci       Date:  2015-09-23       Impact factor: 9.261

10.  Suppression of anti-erythrocyte autoantibody-producing B cells by a physiological IgG-anti-F(ab')2 antibody and escape from suppression by tumour transformation; a model relevant for the pathogenesis of autoimmune haemolytic anaemia.

Authors:  P Terness; U Marx; G Sandilands; D Roelcke; M Welschof; G Opelz
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.